X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
index medicus (29) 29
female (25) 25
male (24) 24
colorectal cancer (22) 22
oncology (17) 17
aged (16) 16
genetics & heredity (16) 16
middle aged (15) 15
animals (14) 14
cancer (14) 14
research (14) 14
mice (13) 13
mutation (13) 13
prognosis (13) 13
adult (12) 12
expression (11) 11
genetic aspects (11) 11
immunohistochemistry (11) 11
aged, 80 and over (10) 10
colon-cancer (10) 10
cell biology (9) 9
lung neoplasms - genetics (9) 9
colorectal-cancer (8) 8
biochemistry (7) 7
cell line, tumor (7) 7
chemistry (7) 7
colorectal neoplasms, hereditary nonpolyposis - genetics (7) 7
lung neoplasms - pathology (7) 7
oncology, experimental (7) 7
tumors (7) 7
adenocarcinoma - genetics (6) 6
beer (6) 6
colon (6) 6
compositions or test papers therefor (6) 6
condition-responsive control in microbiological orenzymological processes (6) 6
dna methylation (6) 6
enzymology (6) 6
gastroenterology & hepatology (6) 6
hnpcc (6) 6
investigating or analysing materials by determining theirchemical or physical properties (6) 6
measuring (6) 6
measuring or testing processes involving enzymes, nucleicacids or microorganisms (6) 6
metallurgy (6) 6
microbiology (6) 6
molecular sequence data (6) 6
mutation or genetic engineering (6) 6
mutations (6) 6
neoplasm staging (6) 6
pathology (6) 6
physics (6) 6
polymerase chain reaction (6) 6
processes of preparing such compositions (6) 6
proto-oncogene proteins - genetics (6) 6
spirits (6) 6
testing (6) 6
vinegar (6) 6
wine (6) 6
alleles (5) 5
analysis (5) 5
carcinoma, non-small-cell lung - genetics (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
colonic neoplasms - genetics (5) 5
digestive system diseases (5) 5
follow-up studies (5) 5
gene expression regulation, neoplastic (5) 5
genes (5) 5
in situ hybridization, fluorescence (5) 5
lung cancer (5) 5
lung cancer, non-small cell (5) 5
lung neoplasms - metabolism (5) 5
mcc (5) 5
medical research (5) 5
methylation (5) 5
microsatellite instability (5) 5
nonpolyposis colorectal-cancer (5) 5
phenotype (5) 5
protein binding (5) 5
research article (5) 5
respiratory system (5) 5
retrospective studies (5) 5
tumorigenesis (5) 5
adaptor proteins, signal transducing (4) 4
apoptosis (4) 4
carcinoma (4) 4
carcinoma, non-small-cell lung - metabolism (4) 4
chemotherapy (4) 4
chromosome mapping (4) 4
colon cancer (4) 4
colonic neoplasms - pathology (4) 4
càncer colorectal (4) 4
dna mismatch repair (4) 4
gene (4) 4
gene expression (4) 4
gene rearrangement (4) 4
genetic diseases (4) 4
genetics (4) 4
hematology, oncology and palliative medicine (4) 4
identification (4) 4
inflammation (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Histopathology, ISSN 0309-0167, 02/2017, Volume 70, Issue 3, pp. 402 - 411
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2011, Volume 6, Issue 7, pp. 1179 - 1189
Lung cancer is the leading cause of cancer-related mortality and requires more effective molecular markers of prognosis and therapeutic responsiveness. Special... 
Biomarker | SATB1 | Lung cancer | Prognostic | BRONCHIAL EPITHELIUM | DNA-BINDING | CHROMOSOME 3P | BREAST-CANCER | CIGARETTE-SMOKING | ONCOLOGY | GASTRIC-CANCER | RESPIRATORY SYSTEM | GENE-EXPRESSION | HISTOLOGIC TYPE | DOMAIN-MEDIATED DIMERIZATION | RISK-ASSESSMENT | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Tissue Array Analysis | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Epigenesis, Genetic | Humans | Lung Neoplasms - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Chromatin Immunoprecipitation | Aged, 80 and over | Adult | Antimetabolites, Antineoplastic - pharmacology | Female | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Hydroxamic Acids - pharmacology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Matrix Attachment Region Binding Proteins - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Azacitidine - analogs & derivatives | Blotting, Western | Azacitidine - pharmacology | Matrix Attachment Region Binding Proteins - genetics | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Aged | Neoplasm Staging | DNA Methylation - drug effects | Cohort Studies
Journal Article
by Thompson, Bryony A and Spurdle, Amanda B and Plazzer, John-Paul and Greenblatt, Marc S and Akagi, Kiwamu and Al-Mulla, Fahd and Bapat, Bharati and Bernstein, Inge and Capellá, Gabriel and den Dunnen, Johan T and du Sart, Desiree and Fabre, Aurelie and Farrell, Michael P and Farrington, Susan M and Frayling, Ian M and Frebourg, Thierry and Goldgar, David E and Heinen, Christopher D and Holinski-Feder, Elke and Kohonen-Corish, Maija and Robinson, Kristina Lagerstedt and Leung, Suet Yi and Martins, Alexana and Moller, Pal and Morak, Monika and Nystrom, Minna and Peltomaki, Paivi and Pineda, Marta and Qi, Ming and Ramesar, Rajkumar and Rasmussen, Lene Juel and Royer-Pokora, Brigitte and Scott, Rodney J and Sijmons, Rolf and Tavtigian, Sean V and Tops, Carli M and Weber, Thomas and Wijnen, Juul and Woods, Michael O and Macrae, Finlay and Genuardi, Maurizio and Castillejo, Adela and Sexton, Aienne and Chan, Anthony K. W and Viel, Alessana and Blanco, Amie and French, Amy and Laner, Aneas and Wagner, Anja and van den Ouweland, Ans and Mensenkamp, Arjen and Payá, Artemio and Betz, Beate and Redeker, Bert and Smith, Betsy and Espenschied, Carin and Cummings, Carole and Engel, Christoph and Fornes, Claudia and Valenzuela, Cristian and Alenda, Cristina and Buchanan, Daniel and Barana, Daniela and Konstantinova, Darina and Cairns, Dianne and Glaser, Elizabeth and Silva, Felipe and Lalloo, Fiona and Crucianelli, Francesca and Hogervorst, Frans and Casey, Graham and Tomlinson, Ian and Blanco, Ignacio and Villar, Isabel López and Garcia-Planells, Javier and Bigler, Jeanette and Shia, Jinru and Martinez-Lopez, Joaquin and Gille, Johan J. P and Hopper, John and Potter, John and Soto, José Luis and Kantelinen, Jukka and Ellis, Kate and Mann, Kirsty and Varesco, Liliana and Zhang, Liying and Le Marchand, Loic and Marafie, Makia J and Nordling, Margareta and Tibiletti, Maria Grazia and Kahan, Mariano Ariel and Ligtenberg, Marjolijn and Clendenning, Mark and Jenkins, Mark and Speevak, Marsha and Digweed, Martin and Kloor, Matthias and Hitchins, Megan and Myers, Megan and ... and InSiGHT and on behalf of InSiGHT and Sahlgrenska akademin and Institutionen för biomedicin, avdelningen för medicinsk genetik och klinisk genetik and Göteborgs universitet and Gothenburg University and Institute of Biomedicine, Department of Medical and Clinical Genetics and Sahlgrenska Academy
Nature genetics, ISSN 1061-4036, 2014, Volume 46, Issue 2, pp. 107 - 115
Journal Article
Gut, ISSN 0017-5749, 03/2011, Volume 60, Issue 3, pp. 350 - 360
Background and aims The non-steroidal anti-inflammatory drug sulindac is an effective chemopreventive agent in sporadic colorectal cancer but its potential... 
INDUCIBLE FACTOR-I | EXPERIMENTAL COLITIS | EPITHELIAL-CELLS | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | COLORECTAL-CANCER | INFLAMMATION | TUMOR-FORMATION | KNOCKOUT MICE | HYPOXIA | GASTROENTEROLOGY & HEPATOLOGY | TUMORIGENESIS | Sulindac - pharmacokinetics | Intestinal Mucosa - metabolism | Apoptosis - drug effects | Colonic Neoplasms - prevention & control | Adenocarcinoma - chemically induced | Colonic Neoplasms - chemically induced | Colonic Neoplasms - metabolism | Anticarcinogenic Agents - pharmacokinetics | Carcinogens | Adenocarcinoma - metabolism | Azoxymethane | MutS Homolog 2 Protein - deficiency | Inflammation Mediators - metabolism | Precancerous Conditions - pathology | Anticarcinogenic Agents - adverse effects | Hypoxia-Inducible Factor 1, alpha Subunit - biosynthesis | Drug Evaluation, Preclinical | Anticarcinogenic Agents - therapeutic use | Mice, Inbred C57BL | Sulindac - therapeutic use | Tumor Suppressor Protein p53 - deficiency | Cell Transformation, Neoplastic - metabolism | Sulindac - adverse effects | Colon - metabolism | Mice, Knockout | Gene Expression Regulation - drug effects | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Colonic Neoplasms - pathology | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Mice | Cell Transformation, Neoplastic - drug effects | Precancerous Conditions - chemically induced | Prevention | Models | Dosage and administration | Research | Sulindac | Colorectal cancer | Inflammatory bowel disease | Diet | Efficiency | Rodents | Clinical trials | Inflammation | Mutation | Gene expression | Tumors | Defects | Index Medicus | Abridged Index Medicus
Journal Article
DMM Disease Models and Mechanisms, ISSN 1754-8403, 09/2015, Volume 8, Issue 9, pp. 1093 - 1103
Journal Article
Journal Article